As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...
Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...
GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.
Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
As it gets harder to offer compounded GLP-1s, many telehealth companies are pivoting to hormone replacement therapy.
Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...
The news has been littered with stories these days about people losing weight using GLP-1 weight loss drugs like Ozempic. Now ...
Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...